Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Glutamate NMDA receptor; Grin1/Grin2b | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | glutamate receptor NMDA | Glutamate NMDA receptor; Grin1/Grin2b | 938 aa | 933 aa | 39.1 % |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | Glutamate NMDA receptor; Grin1/Grin2b | 938 aa | 822 aa | 23.2 % |
Drosophila melanogaster | NMDA receptor 2 | Glutamate NMDA receptor; Grin1/Grin2b | 938 aa | 878 aa | 27.4 % |
Drosophila melanogaster | Glutamate receptor IA | Glutamate NMDA receptor; Grin1/Grin2b | 938 aa | 979 aa | 23.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.1501 | 0.8121 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0583 | 0.3043 | 0.3747 |
Echinococcus multilocularis | smad | 0.0058 | 0.0141 | 0.0174 |
Schistosoma mansoni | hypothetical protein | 0.0583 | 0.3043 | 0.3637 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0758 |
Echinococcus granulosus | Smad4 | 0.0058 | 0.0141 | 0.0174 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0143 | 0.0615 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0758 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0143 | 0.0615 | 0.0758 |
Loa Loa (eye worm) | hypothetical protein | 0.0788 | 0.4178 | 0.4119 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.1501 | 0.8121 | 0.8102 |
Echinococcus granulosus | smad | 0.0058 | 0.0141 | 0.0174 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0583 | 0.3043 | 0.3747 |
Brugia malayi | RNA recognition motif domain containing protein | 0.1501 | 0.8121 | 0.8121 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0143 | 0.0615 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0143 | 0.0615 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.1259 | 0.678 | 0.6779 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0758 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0058 | 0.0141 | 0.0042 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0058 | 0.0141 | 0.0042 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0143 | 0.0615 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.1501 | 0.8121 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0143 | 0.0615 | 1 |
Brugia malayi | Smad1 | 0.0058 | 0.0141 | 0.0139 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0758 |
Loa Loa (eye worm) | Smad1 | 0.0058 | 0.0141 | 0.0042 |
Brugia malayi | MH1 domain containing protein | 0.0058 | 0.0141 | 0.0139 |
Schistosoma mansoni | tar DNA-binding protein | 0.1501 | 0.8121 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0583 | 0.3043 | 0.3637 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0583 | 0.3043 | 0.3747 |
Brugia malayi | hypothetical protein | 0.0788 | 0.4178 | 0.4177 |
Schistosoma mansoni | hypothetical protein | 0.0583 | 0.3043 | 0.3637 |
Brugia malayi | MH2 domain containing protein | 0.0058 | 0.0141 | 0.0139 |
Brugia malayi | MH1 domain containing protein | 0.0058 | 0.0141 | 0.0139 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0583 | 0.3043 | 0.3042 |
Echinococcus granulosus | tar DNA binding protein | 0.1501 | 0.8121 | 1 |
Echinococcus multilocularis | Smad4 | 0.0058 | 0.0141 | 0.0174 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0058 | 0.0141 | 0.0174 |
Echinococcus multilocularis | tar DNA binding protein | 0.1501 | 0.8121 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1259 | 0.678 | 0.8319 |
Brugia malayi | Isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0613 |
Brugia malayi | hypothetical protein | 0.005 | 0.01 | 0.0098 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0058 | 0.0141 | 0.0174 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0844 | 0.449 | 0.4434 |
Echinococcus granulosus | GPCR family 2 | 0.0583 | 0.3043 | 0.3747 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.052 |
Brugia malayi | TAR-binding protein | 0.1501 | 0.8121 | 0.8121 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0758 |
Brugia malayi | MH2 domain containing protein | 0.0844 | 0.449 | 0.4489 |
Echinococcus multilocularis | GPCR, family 2 | 0.0583 | 0.3043 | 0.3747 |
Brugia malayi | MH2 domain containing protein | 0.0058 | 0.0141 | 0.0139 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0058 | 0.0141 | 0.0174 |
Loa Loa (eye worm) | hypothetical protein | 0.1841 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0583 | 0.3043 | 0.2973 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0583 | 0.3043 | 0.3747 |
Onchocerca volvulus | 0.0788 | 0.4178 | 0.5 | |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0583 | 0.3043 | 0.2973 |
Brugia malayi | RNA binding protein | 0.1501 | 0.8121 | 0.8121 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0143 | 0.0615 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.1501 | 0.8121 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0143 | 0.0615 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1259 | 0.678 | 0.6748 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0594 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0844 | 0.449 | 0.4434 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0143 | 0.0615 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0583 | 0.3043 | 0.3637 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0143 | 0.0615 | 1 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0058 | 0.0141 | 0.0174 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0143 | 0.0615 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0583 | 0.3043 | 0.3042 |
Loa Loa (eye worm) | RNA binding protein | 0.1501 | 0.8121 | 0.8102 |
Schistosoma mansoni | tar DNA-binding protein | 0.1501 | 0.8121 | 1 |
Brugia malayi | isocitrate dehydrogenase | 0.0143 | 0.0615 | 0.0613 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.1841 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.1841 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.1501 | 0.8121 | 0.8102 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.12 uM | Inhibition of NMDA response at NR1A/2B receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
IC50 (binding) | = 0.12 uM | Inhibition of NMDA response at NR1A/2B receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
IC50 (binding) | = 34 uM | Compound was tested in vitro for inhibition of NMDA response at cloned NR1A/2C receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
IC50 (binding) | = 34 uM | Compound was tested in vitro for inhibition of NMDA response at cloned NR1A/2C receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
IC50 (binding) | = 38 uM | Compound was tested in vitro for inhibition of NMDA response at cloned NR1A/2A receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
IC50 (binding) | = 38 uM | Compound was tested in vitro for inhibition of NMDA response at cloned NR1A/2A receptor expressed in Xenopus oocytes | ChEMBL. | 10522697 |
MED (functional) | = 10 mg kg-1 | Compound was tested in vivo for potentiation of L-DOPA effect in 6-hydroxydopamine-lesioned rat when administered per orally | ChEMBL. | 10522697 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.